Skip to content


News Posted on December 8, 2010

Fenwick & West TESLaw ‘Personalized Medicine’ Symposium Online

The third annual symposium in the Technology, Entrepreneurship, Science, and the Law (TESLaw) series sponsored by Fenwick & West brought a large audience of attorneys, industry professionals, academic experts, students, and alumni to King Hall for "Personalized Medicine: Getting the Prescription Right" on November 5.  The event is now available for online viewing by following the link below.

Highlights of the symposium included a panel discussion that touched on the recent federal court ruling in the landmark patent suit Association for Molecular Pathology v. United States Patent and Trademark Office.  The panel featured Mark Capone, President of Myriad Genetic Laboratories and Barbara Brenner, Executive Director of Breast Cancer Action, who are key figures from opposing sides of the litigation.  Video of the panel and other events from the symposium can be viewed by following the link below.

The symposium also included a keynote speech from Kathryn Lowell, California Deputy Secretary for Life Sciences and Health Systems, and the state's point person for health care information and technology policy.  Following introductory remarks from Dean Kevin R. Johnson and Fenwick & West Partner David Bell, Lowell explained that personalized health care is care "that fits the individual, ushered in by the sequencing of the human genome, enhanced by the furtherance of new biological technologies."  Personalized health care can both reduce costs and improve treatment, said Lowell, and California is in position to be a leader in the field. 

The symposium also featured a series of panel discussions, beginning with a morning session on "From the Lab to the Patient: Intellectual Property in Personalized Medicine," moderated by Professor Peter Lee and featuring panelists Capone, Brenner, Clinton Neagley, Associate Director, UC Davis InnovationAccess - Technology Transfer Services; and Michael Shuster, Partner, Fenwick & West. 

Following the noon keynote address was a panel on "Issues for Entrepreneurs in the Nascent Industry," moderated by Stephen Graham, Partner, Fenwick & West; with panelists Rowan E. Chapman of Mohr Davidow Ventures; Marc Hellerstein, co-founder of Kinemed; and  Garrett Vygantas, Entrepreneur-In-Residence/Director, Venture Group, Burrill & Co. 

The final panel, "Consumers in the New Personalized Medicine Model," was moderated by Professor Lisa Ikemoto and featured Sandra Soo-Jin Lee of the Center for Biomedical Ethics, Stanford Medical School; Beatrice O'Keefe of the Laboratory Field Services at the state Department of Public Health; and Michael Wilkes, Vice Dean of the School of Medicine and Director of Global Health, UC Davis Health Systems. Among the King Hall faculty in attendance were Associate Dean Vikram Amar and Professors Afra Afsharipour, Alan Brownstein, and Anupam Chander. 

The TESLaw Lecture Series, generously sponsored by Fenwick & West, is a five-year program of annual symposia focused on providing practitioners, academics, and students with the knowledge base to successfully address the challenges inherent to the computing, digital communications, social media, "clean" technology, and life sciences and biotechnology markets of the 21st century. 

TESLAW Symposium Video